Biblio

Found 44 results
Author Keyword Title Type [ Year(Asc)]
Filters: Author is Jan B Vermorken  [Clear All Filters]
2005
A. du Bois, Quinn, M., Thigpen, T., Vermorken, J. B., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Neijt, J. P., Oza, A. M., Ozols, R., Parmar, M. K. B., Pecorelli, S., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Stuart, G. C. E., Trimble, E. L., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., and Wagner, U., 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)., Ann Oncol, vol. 16 Suppl 8, pp. viii7-viii12, 2005.
G. C. E. Stuart, Åvall-Lundqvist, E., du Bois, A., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Oza, A. M., Ozols, R., Parmar, M. K. B., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Trimble, E. L., Thigpen, T., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., Vermorken, J. B., and Wagner, U., 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration., Ann Oncol, vol. 16 Suppl 8, pp. viii36-viii38, 2005.
J. B. Vermorken, Parmar, M. K. B., Brady, M. F., Eisenhauer, E., Högberg, T., Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S., Verheijen, R. H. M., InterGroup, G. Cancer, ,, /NCRI, M. R. C., ,, -CTG, N. C. I. C., ,, -OVAR, A. G. O., and , Clinical trials in ovarian carcinoma: study methodology, Ann Oncol, vol. 16 Suppl 8, pp. viii20-viii29, 2005.
J. B. Vermorken, Parmar, M. K. B., Brady, M. F., Eisenhauer, E., Högberg, T., Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S., and Verheijen, R. H. M., Clinical trials in ovarian carcinoma: study methodology., Ann Oncol, vol. 16 Suppl 8, pp. viii20-viii29, 2005.
J. B. Vermorken, Åvall-Lundqvist, E., Pfisterer, J., Bacon, M., ,, -OVAR, A. G. O., ,, -GCC, E. O. R. T. C., ,, ,, ,, ,, ,, -CTG, N. C. I. C., -US, N. C. I., ,, ,, and , The Gynecologic Cancer Intergroup (GCIG): History and current status, Ann Oncol, vol. 16 Suppl 8, pp. viii39-viii42, 2005.
J. B. Vermorken, Åvall-Lundqvist, E., Pfisterer, J., and Bacon, M., The Gynecologic Cancer Intergroup (GCIG): history and current status., Ann Oncol, vol. 16 Suppl 8, pp. viii39-viii42, 2005.
M. Quinn, Åvall-Lundqvist, E., du Bois, A., Vermorken, J. B., Parmar, M. K. B., Pfisterer, J., Stuart, G. C. E., Thigpen, T., and Neijt, J., History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004., Ann Oncol, vol. 16 Suppl 8, pp. viii5-viii6, 2005.
2003
F. H. van Wijk, Aapro, M. S., Bolis, G., Chevallier, B., van der Burg, M. E. L., Poveda, A. M., de Oliveira, C. F., Tumolo, S., V. di Palumbo, S., Piccart, M. J., Franchi, M., Zanaboni, F., Lacave, A. J., Fontanelli, R., Favalli, G., Zola, P., Guastalla, J. P., Rosso, R., Marth, C., Nooij, M. A., Presti, M., Scarabelli, C., Splinter, T. A., Ploch, E., Beex, L. V., Huinink, W. W. ten Bok, Forni, M., Melpignano, M., Blake, P., Kerbrat, P., Mendiola, C., Cervantes, A., Goupil, A., Harper, P. G., Madronal, C., Namer, M., Scarfone, G., Stoot, J. E., Teodorovic, I., Coens, C., Vergote, I. B., Vermorken, J. B., Research, E. Organisati, and Group, Tof Cancer, Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group, Ann Oncol, vol. 14, pp. 441-8, 2003.
F. H. van Wijk, Aapro, M. S., Bolis, G., Chevallier, B., van der Burg, M. E. L., Poveda, A. M., de Oliveira, C. F., Tumolo, S., V. di Palumbo, S., Piccart, M. J., Franchi, M., Zanaboni, F., Lacave, A. J., Fontanelli, R., Favalli, G., Zola, P., Guastalla, J. P., Rosso, R., Marth, C., Nooij, M. A., Presti, M., Scarabelli, C., Splinter, T. A. W., Ploch, E., Beex, L. V., Huinink, W. W. ten Bok, Forni, M., Melpignano, M., Blake, P., Kerbrat, P., Mendiola, C., Cervantes, A., Goupil, A., Harper, P. G., Madronal, C., Namer, M., Scarfone, G., Stoot, J. E. G. M., Teodorovic, I., Coens, C., Vergote, I. B., and Vermorken, J. B., Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group., Ann Oncol, vol. 14, no. 3, pp. 441-8, 2003.
J. B. Trimbos, Vergote, I. B., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., Giurgea, L., Timmers, P., Coens, C., Pecorelli, S., Collaborators, E. O. R. T. C. - A. C. T. I. O. N., Research, E. Organisati, and Neoplasm, Tof Cancer-, Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial, J Natl Cancer Inst, vol. 95, pp. 113-25, 2003.
J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.
M. J. Piccart, Floquet, A., Scarfone, G., Willemse, P. H., Emerich, J., Vergote, I. B., Giurgea, L., Coens, C., Awada, A., and Vermorken, J. B., Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy, Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 196-203, 2003.

Pages